Recombinant Staphylococcus aureus (strain N315) Staphylococcal complement inhibitor from MYBIOSOURCE INC.
Search, find, compare suppliers for Recombinant Staphylococcus aureus (strain N315) Staphylococcal complement inhibitor products.
| Edit | |
|---|---|
| Product Name | Recombinant Staphylococcus aureus (strain N315) Staphylococcal complement inhibitor |
| Description | Sequence: 32-116aa; Full Length. Purity >90% as determined by SDS-PAGE. Involved in countering the first line of host defense mechanisms. Efficiently inhibits opsonization, phagocytosis and killing of S. aureus by human neutrophils. Acts by binding and stabilizing human C3 convertases (C4b2a and C3bBb), leading to their inactivation. The convertases are no longer able to cleave complement C3, therefore preventing further C3b deposition on the bacterial surface and phagocytosis of the bacterium. Also prevents C5a-induced neutrophil responses (By similarity). MW: 25.78kD |
| Size | 0.01 mg (Yeast), 0.01 mg (E. coli), 0.05 mg (Yeast) |
| Concentration | n/a |
| Applications | n/a |
| Other Names | [SCIN], [scn; SCIN] |
| Gene, Accession, CAS # | [scn], NCBI: WP_000702262.1, UniProt: Q99SU9 |
| Catalog # | MBS1337200 |
| Price | $230, $235, $305 |
| Order / More Info | Recombinant Staphylococcus aureus (strain N315) Staphylococcal complement inhibitor from MYBIOSOURCE INC. |
| Product Specific References | Whole genome sequencing of meticillin-resistant Staphylococcus aureus.Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M., Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y. Hiramatsu K.Lancet 357:1225-1240(2001) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Products